Pular para o conteúdo
Merck

Influence of copolymer composition on the phase behavior of solid dispersions.

Molecular pharmaceutics (2014-10-09)
Anke Prudic, Tobias Kleetz, Marcel Korf, Yuanhui Ji, Gabriele Sadowski
RESUMO

The incorporation of poorly soluble active pharmaceutical ingredients (APIs) into excipients (e.g., polymers) to formulate an amorphous solid dispersion is a promising strategy to improve the oral bioavailability of the API. The application of copolymer excipients allows access to combinations of different monomers and thus to the design of excipients to improve solid-dispersion properties. In this work, the thermodynamic phase behavior of solid dispersions was investigated as a function of the API, type of monomer, and copolymer composition. The glass-transition temperatures and API solubilities in the solid dispersions of naproxen and indomethacin in polyvinylpyrrolidone, polyvinyl acetate, and copolymers with different weight fractions of vinylpyrrolidone and vinyl actetate were investigated. It is shown that the thermodynamic phase behavior of API/copolymer solid dispersions is a function of monomer type and copolymer composition. This effect was also predicted by using the perturbed-chain statistical associating fluid theory (PC-SAFT). The glass-transition temperature of the solid dispersions was calculated with the Gordon-Taylor equation.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Indometacina, 98.5-100.5% (in accordance with EP)
Supelco
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Indometacina, meets USP testing specifications
Supelco
Indometacina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid, 98%
Sigma-Aldrich
Naproxen, meets USP testing specifications
Naproxen, European Pharmacopoeia (EP) Reference Standard
Supelco
Naproxen, VETRANAL®, analytical standard
Indometacina, European Pharmacopoeia (EP) Reference Standard